KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Pacific Biosciences Of California (PACB) Depreciation Expense (2022 - 2025)

Historic Depreciation Expense for Pacific Biosciences Of California (PACB) over the last 4 years, with Q3 2025 value amounting to $2.5 million.

  • Pacific Biosciences Of California's Depreciation Expense fell 4130.69% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 592.33%. This contributed to the annual value of $13.8 million for FY2024, which is 2000.0% up from last year.
  • As of Q3 2025, Pacific Biosciences Of California's Depreciation Expense stood at $2.5 million, which was down 4130.69% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Depreciation Expense peaked at $5.1 million during Q1 2025, and registered a low of $2.3 million during Q1 2022.
  • For the 4-year period, Pacific Biosciences Of California's Depreciation Expense averaged around $3.0 million, with its median value being $2.8 million (2023).
  • Over the last 5 years, Pacific Biosciences Of California's Depreciation Expense had its largest YoY gain of 5836.42% in 2025, and its largest YoY loss of 4130.69% in 2025.
  • Quarter analysis of 4 years shows Pacific Biosciences Of California's Depreciation Expense stood at $2.6 million in 2022, then rose by 17.56% to $3.0 million in 2023, then decreased by 4.81% to $2.9 million in 2024, then decreased by 14.19% to $2.5 million in 2025.
  • Its Depreciation Expense stands at $2.5 million for Q3 2025, versus $2.7 million for Q2 2025 and $5.1 million for Q1 2025.